{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T02:25:41Z","timestamp":1791771941872,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ejmech.2022.114379","type":"journal-article","created":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T16:21:54Z","timestamp":1650471714000},"page":"114379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Synthesis and biological evaluation of geniposide derivatives as inhibitors of hyperuricemia, inflammatory and fibrosis"],"prefix":"10.1016","volume":"237","author":[{"given":"Jia-shu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu-xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-kai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-yue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-fa","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.114379_bib1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.7326\/0003-4819-143-7-200510040-00009","article-title":"Pathogenesis of gout","volume":"143","author":"Choi","year":"2005","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejmech.2022.114379_bib2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2147\/VHRM.S4265","article-title":"Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress","volume":"5","author":"George","year":"2009","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.ejmech.2022.114379_bib3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11926-996-0044-0","article-title":"Renal urate handling: clinical relevance of recent advances","volume":"7","author":"Anzai","year":"2005","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.ejmech.2022.114379_bib4","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.biopha.2018.07.077","article-title":"CXCR1\/CXCR2 antagonist G31P inhibits nephritis in a mouse model of uric acid nephropathy","volume":"107","author":"Ye","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2022.114379_bib5","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1681\/ASN.2014080793","article-title":"EGF receptor inhibition alleviates hyperuricemic nephropathy","volume":"26","author":"Liu","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejmech.2022.114379_bib6","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/med.21457","article-title":"Toward an understanding of structural insights of xanthine and aldehyde oxidases: an overview of their inhibitors and role in various diseases","volume":"38","author":"Kumar","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2022.114379_bib7","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/cmdc.201900034","article-title":"Inhibitors of xanthine oxidase: scaffold diversity and structure-based drug design","volume":"14","author":"Luna","year":"2019","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2022.114379_bib8","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/art.40583","article-title":"New perspectives in rheumatology: implications of the cardiovascular safety of febuxostat and allopurinol in patients with gout and cardiovascular morbidities trial and the associated food and drug administration public safety alert","volume":"70","author":"Choi","year":"2018","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejmech.2022.114379_bib9","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s40261-018-0699-0","article-title":"Multicenter, open label study of long-term topiroxostat (FYX-051) administration in Japanese hyperuricemic patients with or without gout","volume":"38","author":"Hosoya1","year":"2018","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.ejmech.2022.114379_bib10","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/jcpt.12391","article-title":"Comparison of topiroxostat and allopurinol in Japanese hyperuricemic patients with or without gout: a phase 3, multicentre, randomized, double-blind, double dummy, active-controlled, parallel-group study","volume":"41","author":"Hosoya","year":"2016","journal-title":"J. Clin. Pharm. Therapeut."},{"key":"10.1016\/j.ejmech.2022.114379_bib11","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1007\/s10157-018-1530-1","article-title":"Uric acid-lowering and renoprotective effects of topiroxostat, a selective xanthine oxidoreductase inhibitor, in patients with diabetic nephropathy and hyperuricemia: a randomized, double-blind, placebo controlled, parallel-group study (UPWARD study)","volume":"22","author":"Wada","year":"2018","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.ejmech.2022.114379_bib12","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.2042-7158.2011.01256.x","article-title":"Hepatoprotective effects of geniposide in a rat model of nonalcoholic steatohepatitis","volume":"63","author":"Ma","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114379_bib13","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00011-009-0118-3","article-title":"Geniposide inhibits interleukin-6 and interleukin-8 production in lipopolysaccharide-induced human umbilical vein endothelial cells by blocking p38 and ERK1\/2 signaling pathways","volume":"59","author":"Liu","year":"2010","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ejmech.2022.114379_bib14","first-page":"721","article-title":"Effect of jasminoides on potassium oxonate-induced hyperuricemia in mice and its mechanism","volume":"10","author":"Hu","year":"2011","journal-title":"Central South Pharm."},{"key":"10.1016\/j.ejmech.2022.114379_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2019.05.011","article-title":"Anti-hyperuricemic and nephroprotective effect of geniposide in chronic hyperuricemia mice","volume":"61","author":"Liu","year":"2019","journal-title":"J. Funct.Foods"},{"key":"10.1016\/j.ejmech.2022.114379_bib16","doi-asserted-by":"crossref","first-page":"105321","DOI":"10.1016\/j.bioorg.2021.105321","article-title":"Design, synthesis and bioactive evaluation of geniposide derivatives for antihyperuricemic and nephroprotective effects","volume":"116","author":"Wang","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.114379_bib17","doi-asserted-by":"crossref","first-page":"10723","DOI":"10.1073\/pnas.97.20.10723","article-title":"Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: structurebased mechanism of conversion","volume":"97","author":"Bryan","year":"2000","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ejmech.2022.114379_bib18","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1124\/jpet.104.070433","article-title":"Y-700 [1-[3-cyano-4-(2,2-dimethylpropoxy) phenyl]-1Hpyrazole-4-carboxylic acid]: a potent xanthine oxidoreductase inhibitor with hepatic excretion","volume":"311","author":"Fukunari","year":"2004","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2022.114379_bib19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejmech.2015.08.056","article-title":"Synthesis and evaluation of 1-hydroxy\/methoxy-4-methyl-2-phenyl-1H-imidazole-5- carboxylic acid derivatives as non-purine xanthine oxidase inhibitors","volume":"103","author":"Chen","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114379_bib20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bmc.2021.116117","article-title":"Synthesis and biological evaluation of 2-(4-alkoxy-3-cyano) phenylpyrimidine derivatives with 4-amino or 4- hydroxy as a pharmacophore element binding with xanthine oxidase active site","volume":"38","author":"Sun","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114379_bib21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11926-996-0044-0","article-title":"Renal urate handling: clinical relevance of recent advances","volume":"7","author":"Anzai","year":"2005","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.ejmech.2022.114379_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1371\/journal.pmed.0050197","article-title":"SLC2A9 is a high-capacity urate transporter in humans","volume":"5","author":"Caulfield","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.ejmech.2022.114379_bib23","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1021\/jf505584m","article-title":"Novel insights into the inhibitory mechanism of kaempferol on xanthine oxidase","volume":"63","author":"Wang","year":"2015","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2022.114379_bib24","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0960-894X(01)00093-2","article-title":"Synthesis and structure-activity relationships of 1-phenylpyrazoles as xanthine oxidase inhibitors","volume":"11","author":"Ishibuchi","year":"2001","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.114379_bib25","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1074\/jbc.M208307200","article-title":"An extremely potent inhibitor of xanthine oxidoreductase","volume":"278","author":"Okamoto","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2022.114379_bib26","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1016\/j.ejmech.2010.02.013","article-title":"Synthesis of some 5-phenylisoxazole-3-carboxylic acid derivatives as potentxanthine oxidase inhibitors","volume":"45","author":"Wang","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114379_bib27","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.ejmech.2018.01.096","article-title":"Design, synthesis and biological evaluation of novel xanthine oxidase inhibitors bearing a 2-arylbenzo[b]furan scaffold","volume":"151","author":"Tang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114379_bib28","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1021\/jf5004094","article-title":"Inhibition of xanthine oxidase by Rhodiola crenulata extracts and their phytochemicals","volume":"62","author":"Chu","year":"2014","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2022.114379_bib29","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bmcl.2008.10.122","article-title":"Design, synthesis, and pharmacological and pharmacokinetic evaluation of 3-phenyl-5-pyridyl-1,2,4-triazole derivatives as xanthine oxidoreductase inhibitors","volume":"19","author":"Sato","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.114379_bib30","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0960-894X(01)00093-2","article-title":"Synthesis and structure-activity relationships of 1-phenylpyrazoles as xanthine oxidase inhibitors","volume":"11","author":"Ishibuchi","year":"2001","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.114379_bib31","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/cbdd.13114","article-title":"Design, synthesis, and biological evaluation of 5-(4-(pyridin-4-yl)-1H-1,2,3-triazol-1-yl)benzonitrile derivatives as xanthine oxidase inhibitors","volume":"91","author":"Zhang","year":"2018","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2022.114379_bib32","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.ijbiomac.2018.09.001","article-title":"Coumarin derivatives as promising xanthine oxidase inhibitors","volume":"120","author":"Fais","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2022.114379_bib33","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2353\/ajpath.2008.080433","article-title":"Duffifield. Pericytes and perivascular fifibroblasts are the primary source of collagen-producing cells in obstructive fifibrosis of the kidney","volume":"173","author":"Lin","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejmech.2022.114379_bib34","doi-asserted-by":"crossref","DOI":"10.5812\/numonthly.7(3)2015.27233","article-title":"Associations between hyperuricemia and chronic kidney disease: a review","volume":"7","author":"Prasad Sah","year":"2015","journal-title":"Nephro-Urol. Mon."},{"key":"10.1016\/j.ejmech.2022.114379_bib35","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000481668","article-title":"High uric acid-induced epithelial-mesenchymal transition of renal tubular epithelial cells via the TLR4\/NF-kB signaling pathway","volume":"46","author":"Liu","year":"2017","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.ejmech.2022.114379_bib36","doi-asserted-by":"crossref","first-page":"F471","DOI":"10.1152\/ajprenal.00560.2012","article-title":"Uric acid-induced phenotypic transition of renal tubular cells as a novel mechanism of chronic kidney disease","volume":"304","author":"Ryu","year":"2013","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.ejmech.2022.114379_bib37","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1039\/C6FO00822D","article-title":"Hypouricemic effects of Mesona procumbens Hemsl. through modulating xanthine oxidase activity in vitro and in vivo","volume":"7","author":"Jhang","year":"2016","journal-title":"Food Funct."},{"key":"10.1016\/j.ejmech.2022.114379_bib38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/art.23245","article-title":"Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the Third National Health and Nutrition Examination Survey","volume":"59","author":"Choi","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejmech.2022.114379_bib39","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/ndt\/gfg140","article-title":"Increased expression of monocyte chemoattractant protein-1 (MCP-1) by renal epithelial cells in culture on exposure to calcium oxalate, phosphate and uric acid crystals","volume":"18","author":"Umekawa","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejmech.2022.114379_bib40","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000343567","article-title":"Reducing serum uric acid attenuates TGF-\u03b21-induced profibrogenic progression in type 2 diabetic nephropathy","volume":"121","author":"Kim","year":"2012","journal-title":"Nephron Exp. Nephrol."},{"key":"10.1016\/j.ejmech.2022.114379_bib41","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/nrm2297","article-title":"TGF beta-SMAD signal transduction: molecular specificity and functional flexibility","volume":"8","author":"Schmierer","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2022.114379_bib42","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2353\/ajpath.2008.080433","article-title":"Pericytes and perivascular fifibroblasts are the primary source of collagen-producing cells in obstructive fifibrosis of the kidney","volume":"173","author":"Lin","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejmech.2022.114379_bib43","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nature06939","article-title":"Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants","volume":"453","author":"Eisenbarth","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2022.114379_bib44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4196\/kjpp.2012.16.2.107","article-title":"3,4,5-Trihydroxycinnamic acid inhibits LPS-induced iNOS expression by suppressing NF-\u03baB activation in BV2 microglial cells","volume":"16","author":"Lee","year":"2012","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114379_bib45","doi-asserted-by":"crossref","first-page":"31980","DOI":"10.1074\/jbc.M304278200","article-title":"Differential phosphorylation of the signal responsive domain of I\u03baB\u03b1 and I\u03baB\u03b2 by I\u03baB kinases","volume":"278","author":"Wu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2022.114379_bib46","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.foodchem.2014.06.022","article-title":"Trilobatin attenuates the LPS-mediated inflammatory response by suppressing the NF-\u03baB signaling pathway","volume":"166","author":"Fan","year":"2015","journal-title":"Food Chem."},{"key":"10.1016\/j.ejmech.2022.114379_bib47","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1681\/ASN.2010020143","article-title":"The NLRP3 inflammasome promotes renal inflammation and contributes to CKD","volume":"21","author":"Vilaysane","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejmech.2022.114379_bib48","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1039\/C8FO02124D","article-title":"Hypouricemic and nephroprotective roles of anthocyanins in hyperuricemic mice","volume":"10","author":"Qian","year":"2019","journal-title":"Food Funct."},{"key":"10.1016\/j.ejmech.2022.114379_bib49","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1016\/j.bmcl.2014.07.041","article-title":"Synthesis and evaluation of naphthoflavones as a new class of nonpurine xanthine oxidase inhibitors","volume":"24","author":"Singh","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.114379_bib50","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0963-9969(01)00131-4","article-title":"Characterization of inhibition and stability of soy-Protein Derived angiotensin I-converting enzyme inhibitory peptides","volume":"35","author":"Wu","year":"2002","journal-title":"Food Res. Int."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422002811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422002811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:42:09Z","timestamp":1759329729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422002811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":50,"alternative-id":["S0223523422002811"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114379","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological evaluation of geniposide derivatives as inhibitors of hyperuricemia, inflammatory and fibrosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114379","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114379"}}